April 1-5, 2017
Participants: Juergen Gamer, PhD, VP Business Development
Christian Gieffers, PhD, VP Analytics / Protein Chemistry
Christian Merz, PhD, Head of Cellular Analytics
Meinolf Thiemann, PhD, Director Assay Development
- Talk on April 04, 15:05 - 15:20 pm (Abstract Nr. 4963): "Novel hexavalent GITR agonists stimulate T cells and enhance memory formation"
- Poster (Abstract Nr. 4690 / 6): "Hexavalent CD27 agonists show single agent anti-tumor activity and enhanced memory formation in mouse syngeneic tumor models"
- Poster (Abstract Nr. 1688 / 7): "HERA-CD40L: A novel hexavalent CD40 agonist with superior biological activity"
April 7, 2017
New York, USA
Participant: Thomas Höger, PhD, CEO
Talk: 09:30 - 09:55
Mai 3-6, 2017
Participants: Claudia Kunz, PhD, Director Clinical Development
Alexandra Pinczolits, PhD, Clinical Project Manager
June 24 - 27, 2017
Participants: Meinolf Thiemann, PhD, Director Assay Development
June 25th, 2017, Posterpresentation: "Hexavalent CD27 agonists show single agent anti-tumor activity in mouse
syngeneic tumor models which is augmented by combination with anti-PD-1"